Dr. Christopher M. Vachon
Neurology (Neurology Physician)
11104 Parkview Circle Dr Ste 110
Fort Wayne, IN 46845
Who else practices at this address →
Allen County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- Indiana University School of Medicine (2014)
- Years since graduation
- 12
- In the NPI registry since
- 2014
- Medicare patients seen, 2024
- 230
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2014Medical school: Indiana University School of Medicine
- 2014Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
IN license 01081920A
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Parkview Regional Medical Center Fort Wayne, IN
- Parkview Whitley Hospital Columbia City, IN
- Parkview Dekalb Hospital Auburn, IN
- Parkview Wabash Hospital, Inc Wabash, IN
- Adams Memorial Hospital Decatur, IN
Medical groups
- Parkview Health System Inc (1,377 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 230
- Services billed
- 1,193
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Injection, incobotulinumtoxin a, 1 unit | 6,325 | 13 |
| Established patient office or other outpatient visit, 30-39 minutes | 97 | 72 |
| Established patient office or other outpatient visit, 40-54 minutes | 85 | 63 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 83 | 56 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 71 | 70 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 37 | 16 |
| New patient office or other outpatient visit, 60-74 minutes | 22 | 22 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 21 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Fort Wayne, IN | 171 |
| Gabapentin Other prescribers in Fort Wayne, IN | 103 |
| Emgality Pen (galcanezumab-gnlm) Other prescribers in Fort Wayne, IN | 77 |
| Prednisone Other prescribers in Fort Wayne, IN | 73 |
| Baclofen Other prescribers in Fort Wayne, IN | 72 |
| Carbidopa-Levodopa Er (carbidopa/levodopa) Other prescribers in Fort Wayne, IN | 64 |
| Pyridostigmine Bromide Other prescribers in Fort Wayne, IN | 62 |
| Qulipta (atogepant) Other prescribers in Fort Wayne, IN | 61 |
| Duloxetine Hcl Other prescribers in Fort Wayne, IN | 58 |
| Levetiracetam Other prescribers in Fort Wayne, IN | 52 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 17 companies reported 40 payments worth $10,471 in total to this clinician.
| AbbVie Inc. | $10,028 |
|---|---|
| Eisai Inc. | $63.13 |
| Amgen Inc. | $45.38 |
| Hospira, Inc. | $40.52 |
| Lundbeck LLC | $38.78 |
| Pfizer Inc. | $34.50 |
| Neurocrine Biosciences, Inc. | $33.96 |
| UCB, Inc. | $29.92 |
| Compensation for services other than consulting (speaking, faculty) | $9,750 |
|---|---|
| Food and Beverage | $602 |
| Travel and Lodging | $119 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AbbVie Inc. Dec 4, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $6,500 |
| AbbVie Inc. May 2, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $975 |
| AbbVie Inc. Aug 15, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $975 |
| AbbVie Inc. May 16, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $650 |
| AbbVie Inc. May 16, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $650 |
| AbbVie Inc. Nov 20, 2025 | Travel and Lodging BOTOX · NEUROSCIENCE · travel to MUNCIE, IN · in-kind | $119 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $1,500 in research payments for these studies, mostly to the institutions running them.
- A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.
Ipsen Pharma Sas · Completed · NCT04936542
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.